buy ACAD
entry 1 $44.50 & entry 2 $42.50
sl $38.50
tp.1 $50.50 tp.2 $55.50 Tp.3 $60.00 Tp.4 $70.50 Tp.5 $80.00
many products releasing soon
Sector: Health Technology
Industry: Biotechnology
Employees: 503
ACADIA Pharmaceuticals , Inc. operates as a biopharmaceutical company focused on the development and commercialization of medicines to address unmet medical...
many products releasing soon
Sector: Health Technology
Industry: Biotechnology
Employees: 503
ACADIA Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development and commercialization of medicines to address unmet medical needs in central nervous system, or CNS, disorders. The firms product include Nuplazid, which is used for the...
Hello traders!
Here my idea is to go short on ACAD until the previous resistance line and then wait for a confirmation candle before placing the second trade! Be aware of false break-out and keep an eye on the MACD and RSI. Right now, BULLISH MOMENTUM is declining and RSI is looking downwards BUT things in stock market may change really fast!
Remember to put a...
Hello traders, ACADIA PHARMACEUTICALS is in a downward movement, it is in a compression zone which can break up above great propability if the buyers are there.
Please LIKE & FOLLOW, thank you!
A buy signal is generated. This is a Bullish indicator signaling ACAD's price could rise from here. Traders may explore going long the stock or buying call options. I identified 45 similar cases where ACAD's MACD histogram became positive, and 38 of them led to successful outcomes. Odds of Success: 84%.
This post will be focused on Acadia Pharmaceuticals, a company focused on treatment for Parkinson’s disease psychosis.
ACAD Just recently touched what has been its level of support since end of April. From there ACAD jumped roughly 7% in what seems to be a strong uptrend even after a missing their quarterly earnings target.
ACAD has touched resistance roughly...
Stochastic Oscillator shows upturn for Acadia. Ichimoku Cloud support is very important in this case since today's session is not breaking it and could demonstrate positive trend force.
Please note that biotech companies present high uncertainty.
Disclosure: My articles contain statements and projections based on assumptions on capital markets, and therefore...
Bought $ACAD $20 strike puts with expiration on 1/15/21.
I am calling this a short squeeze. Research published today shows Nuplazid as a promising drug for Parkinsons induced Psychosis. Looking into the research paper, they used a "one sided" P-Value test, which negates the reverse end of the gausian curve. I think they are doctoring the study after mortality...
